Abstract
With the rapid introduction of new treatments for mild COVID-19, GPs need to be aware of the latest information to help them recognise which patients are candidates for available therapies. Treatment options for suitable patients with mild COVID-19 include antivirals and monoclonal antibodies, with the oral antivirals being most relevant for GPs. GPs should always refer to COVID-19 living guidelines to ensure they provide accurate advice to their patients.
| Original language | English |
|---|---|
| Pages (from-to) | 41-47 |
| Number of pages | 7 |
| Journal | Medicine Today |
| Volume | 23 |
| Issue number | 9 |
| Publication status | Published - Sept 2022 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver